Chumakov Center to submit registration application for its C

The Center has its own biotechnological vaccine production line
© Alexander Demyanchuk/TASS
MOSCOW, December 22. /TASS/. The Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences will submit an application to register its vaccine against the coronavirus in late January - early February 2021 and simultaneously will launch Phase Three of trials of the vaccine, Deputy Director General of the Center Konstantin Chernov said in an interview with the Russia-24 TV channel on Tuesday.
"We are going to submit [the paperwork] to register the vaccine in late January - early February. And simultaneously with that we will launch Phase Three [of clinical trials] in order to register it already not according to the provisional government decree No. 441 but according to the permanent federal law No. 61," he said.

Related Keywords

Yekaterinburg , Sverdlovskaya Oblast , Russia , Moscow , Moskva , Chumakov , Stavropol Skiy Kray , Novosibirsk , Novosibirskaya Oblast , Petersburg , Sankt Peterburg , Russian , Soviet , , Chumakov Federal Scientific Center , Center Konstantin Chernov , Academy Of Medical Sciences , Chumakov Center , Products Of The Russian Academy Sciences , Academy Of Medical Sciences Mikhail Chumakov , Institute Of Poliomyelitis , Biological Products , Russian Academy , Phase Three , Deputy Director General , Viral Encephalitides , Soviet Academy , Medical Sciences Mikhail , ரஷ்யா , மாஸ்கோ , மோசிக்குவா , பீட்டர்ஸ்பர்க் , ரஷ்ய , சோவியத் , கலைக்கழகம் ஆஃப் மருத்துவ அறிவியல் , ப்ராடக்ட்ஸ் ஆஃப் தி ரஷ்ய கலைக்கழகம் அறிவியல் , உயிரியல் ப்ராடக்ட்ஸ் , ரஷ்ய கலைக்கழகம் , கட்டம் மூன்று , துணை இயக்குனர் ஜநரல் , சோவியத் கலைக்கழகம் , மருத்துவ அறிவியல் மிகைல் ,